In conclusion, our findings suggested that circulating miR-320b and its target gene MAP3K1 represent potential diagnostic biomarkers and may be involved in the CD4+ T-cell proliferation in SLE. This evidence concerns the gene MAP3K1 and systemic lupus erythematosus.